Isodiol International Inc Share Price Other OTC
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 19.14M 1.5B | Sales 2019 | 22.25M 1.74B | Capitalization | 49.96M 3.91B |
---|---|---|---|---|---|
Net income 2018 | -36M -2.82B | Net income 2019 | -126M -9.86B | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 15.55M 1.22B | Net Debt 2019 | 5.22M 409M | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/17 |
Director/Board Member | - | 29/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 13/02/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/17 |
Director/Board Member | - | 29/08/18 | |
Director/Board Member | - | 20/11/18 |
1st Jan change | Capi. | |
---|---|---|
+39.90% | 6.01B | |
-22.06% | 4.11B | |
+10.94% | 3.28B | |
-18.63% | 2.83B | |
-9.17% | 2.31B | |
+44.13% | 1.9B | |
-5.16% | 1.55B | |
+52.16% | 1.51B | |
-16.04% | 1.49B |